ScholarIQanswers from OpenAlex & ORCID
Manuel Praga
ResearcherPublications, citations & collaboration network
Manuel Praga is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Manuel Praga have?
ScholarIQindexed works
Manuel Praga has 590 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Manuel Praga have?
ScholarIQcitation count
Manuel Praga has 23,743 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Manuel Praga?
ScholarIQh-index
Manuel Praga has an h-index of 78 in OpenAlex.
What is the i10-index of Manuel Praga?
ScholarIQi10-index
Manuel Praga has an i10-index of 272 in OpenAlex.
What is the ORCID of Manuel Praga?
ScholarIQorcid
The ORCID for Manuel Praga is on the source record.
What is the OpenAlex record for Manuel Praga?
ScholarIQopenalex
The OpenAlex for Manuel Praga is on the source record.
What are the most-cited papers on Manuel Praga?
ScholarIQmost cited works
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George Βertsias, Maria G. Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg M. Bajema, Jo H. M. Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frédéric Houssiau, John P. A. Ioannidis, David Isenberg, Cees G. M. Kallenberg, Liz Lightstone, Stephen D. Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimı́r Tesař, Carlos Vasconcelos, Ronald van Vollenhoven, Elena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T. Boumpas
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans‐Joachim Anders, Martin Aringer, Ingeborg M. Bajema, John Boletis, Eleni Frangou, Frédéric Houssiau, Jane Hollis, A. Karras, Francesca Marchiori, Stephen D. Marks, Gabriella Moroni, Marta Mosca, Ioannis Parodis, Manuel Praga, Matthias Schneider, Josef S Smolen, Vladimı́r Tesař, Maria Trachana, Ronald van Vollenhoven, Alexandre E. Voskuyl, Y K Onno Teng, Bernadette van Leew, George Βertsias, David Jayne, Dimitrios T. Boumpas
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
Rosanna Coppo, on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Stéphan Troyanov, Shubha S. Bellur, Daniel C. Cattran, H. Terence Cook, John Feehally, Ian S.D. Roberts, Laura Morando, Roberta Camilla, Vladimı́r Tesař, Sigrid Lunberg, Loreto Gesualdo, Francesco Emma, Cristiana Rollino, Alessandro Amore, Manuel Praga, Sandro Feriozzi, Giuseppe Segoloni, Antonello Pani, Giovanni Cancarini, Magalena Durlik, Elisabetta Moggia, Gianna Mazzucco, C. Giannakakis, Eva Honsová, B. Sundelin, Anna Maria Di Palma, Franco Ferrario, Eduardo Gutiérrez, Anna Maria Asunis, Jonathan Barratt, Regina Tardanico, Agnieszka Perkowska‐Ptasińska
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
Aiko P. J. de Vries, Piero Ruggenenti, Xiong Z. Ruan, Manuel Praga, Josep M. Cruzado, Ingeborg M. Bajema, Vivette D. D’Agati, Hildo J. Lamb, Draženka Pongrac Barlovič, Radovan Hojs, Manuela Abbate, Rosa Rodriquez, Carl Erik Mogensen, Esteban Porrini
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
Bengt Fellström, Jonathan Barratt, H. Terence Cook, Rosanna Coppo, John Feehally, Johan W. de Fijter, Jürgen Floege, Gerd R. Hetzel, Alan G. Jardine, Francesco Locatelli, Bart Maes, Alex Mercer, Fernanda Ortiz, Manuel Praga, Søren Schwartz Sørensen, Vladimı́r Tesař, Lucia Del Vecchio